Risk factors for prostate cancer: Results from the Canadian National Enhanced Cancer Surveillance System

Cancer Causes and Control

Volumn 10, Issue 5, 1999, Pages 355-367

  Villeneuve, Paul J ^a,b   Johnson, Kenneth C ^a   Kreiger, Nancy ^b,c   Mao, Yang ^a   Paulse, Bertha ^d   Dewar, Ron ^d   Dryer, Dagny ^d   Whittaker, Heather ^d   Robson, Diane ^d   Fincham, Shirley ^d   Le, Nhu ^d  

^a LAB CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d NONE

Author keywords

Anthropometry; Cigarette smoking; Diet; Physical activity; Prostate cancer

Indexed keywords

FAT;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CALORIC INTAKE; CANADA; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; FAT INTAKE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; REGRESSION ANALYSIS; TOMATO;

AGED; CANADA; CASE-CONTROL STUDIES; ETHNIC GROUPS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING;

EID: 0032869980     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008958103865     Document Type: Article

References (52)

1. National Cancer Institute of Canada (1997) Canadian Cancer Statistics 1997. Toronto, Canada: NCIC.
2. Boyle P, Maissonneuve P, Napalkov P (1995) Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 46(Suppl. 3A): 47-55.
3. Dijkman GA, Debruyne FM (1996) Epidemiology of prostate cancer. Eur Urol 30: 281-295.
4. World Health Organization (1985) International Classification of Diseases, 9th revision. Geneva: WHO.
5. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990) Family history and risk of prostate cancer. Prostate 17: 337-347.
6. Carter BS, Beaty TH, Steinberg CD, Childs B, Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89: 3367-3371.
7. Block G, Hartman AM, Naughton D (1990) A reduced dietary questionnaire: development and validation. Epidemiology 1: 58-64.
8. Willett WC (1998) Nutritional Epidemiology, 2nd edn. New York: Oxford University Press, pp. 95-97.
9. Health and Welfare Canada (1988) Nutrient Value of Some Common Foods. Ottawa: Ministry of Supply and Services Canada.
10. Setchell KDR, Adlerereutz H (1988) Mammalian lignans and phytoestrogens, recent studies on their formation, metabolism and biological role in health and disease. In: Roland IR, ed. Role of Gut Flora in Toxicity and Cancer. London: Academic Press, pp. 315-345.
11. SAS release version 6.11. Cary NC: Sas Institute Inc.
12. Rothman KJ, Greenland S (1998) Modern Epidemiology, 2nd edn. Philadelphia, PA Lippincott-Raven, pp. 256-257.
13. Carter BS, Carter HB, Isaacs JT (1990) Epidemiology evidence regarding predisposing factors to prostate cancer. Prostate 16: 187-197.
14. Scott R Jr, Mutchnik DH, Laskowski TZ, Schmalhorst WR (1969) Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J Urol 101: 602-607.
15. Levy I, Gibbons L, Collins JP, Perkins DG, Mao Y (1993) Prostate cancer trends in Canada: rising incidence or increased detection? Can Med Assoc J 149: 617-624.
16. Lesko SM, Rosenberg L, Shapiro S (1996) Family history and prostate cancer risk. Am J Epidemiol 144: 1041-1047.
17. Schnatter AR, Acquavella JF, Thompson FS, Donaleski D, Theriault G (1990) An analysis of death ascertainment and follow-up through Statistics Canada's Mortality Data Base system. Can J Public Health 81: 60-65.
18. Nomura AM, Kolonel LN (1991) Prostate cancer: a current perspective. Epidemiol Rev 13: 200-227.
19. Shibata A, Whittemore AS (1997) Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Prostate 32: 65-72.
20. Montie JE, Pienta KJ (1994) Review of the role of androgenic hormones in the epidemiology of benign prostatic hypertrophy and prostate cancer: Urology 43: 892-899.
21. Dai WS, Gutai JP, Kuller LH, Cauley JA (1988) Cigarette smoking and serum sex hormones in men. Am J Epidemiol 128: 796-805.
22. Armstrong BG, Kazantzis G (1985) Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case control study. Br J Ind Med 42: 540-545.
23. Pour PM (1983) Prostatic cancer induced in MRC rats by N-nitrosobis (2-oxopropyl)-amine and N-nitrosobis (2-hydroxypropyllamine. Carcinogenesis 4: 49-55.
24. Cerhan JR, Torner JC, Lynch CF, et al. (1997) Association of smoking, body mass and physical activity with risk of prostate cancer in the lowa 65 + Rural Health Study (United States). Cancer Causes Control 8: 229-238.
25. Statistics Canada (1997) National Population Health Survey: supplements. Ottawa; Statisties Canada, Health Statistics Division.
26. Ghadirian P, Lacroix A, Maisonneuve P, et al. (1996) Nutritional factors and prostate cancer: a case-control study of French Canadians in Montreal, Canada. Cancer Causes Control 7: 428-436.
27. Breslow RA, Weed DL (1998) Review of epidemiologic studies of alcohol and prostate cancer: 1971-1996. Nutr Cancer 30: 1-13.
28. Jain MG, Hislop GT, Howe GR, Burch JD, Ghadirian P (1998) Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78: 707-711.
29. De Stefani E, Fierro L, Barrios E, Ronco A (1995) Tobacco, alcohol, diet and risk of prostate cancer. Tumori 81: 315-320.
30. Thune I, Lund E (1994) Physical activity and the risk of prostate cancer and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 5: 549-556.
31. Lee IM (1995) Exercise and physical health; cancer and immune function. Res Q Exerc Sport 66: 286-291.
32. Dessypris A, Kuoppasalmi K, Adlerercutz H (1976) Plasma cortisol, testosterone, androstenedione, and luteinizing hormone (LH) in a non-competitive marathon run. J Steroid Biochem 7: 33-37.
33. Morville R, Pesquies PC, Guezennec CY, Serrurier BD, Guignard M (1979) Plasma variations in testicular and adrenal androgens during prolonged physical exercise in man. Ann Endocrinol (Paris) 40: 501-510.
34. Oremek GM, Seiffert UB (1996) Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations. Clin in Chem 42: 691-695.
35. Kolonel LN (1996) Nutrition and prostate cancer. Cancer Causes Control 7: 83-94.
36. Whittemore AS, Kolonel LN, Wu AH, et al. (1999) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites and Asians in the United States and Canada. J Natl Cancer Inst 87: 652-661.
37. Talamini R, Franceschi S, La Vecchia C, Guarneri S, Negri E (1993) Smoking habits and prostate cancer: a case control study in northern Italy. Prev Med 22: 400-408.
38. Kolonel LN, Yoshizawa CN, Hankin JH (1988) Diet and prostatic cancer: a case control study in Hawaii. Am J Epidemiol 127: 999-1012.
39. Severson RK, Grove JS, Nomura AMY, Stemmerman GN (1988) Body mass and prostatic cancer: a prospective study. BMJ 297: 713-715.
40. Andersson SO, Baron J, Bergstrom R, Lindgren C, Wolk A, Adami HO (1996) Lifestyle factors and prostate cancer risk: a case control study in Sweden. Cancer Epidemiol Biomarkers Prev 5: 509-513.
41. Adlercreutz H (1990) Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 201: 3-23.
42. Ellison LF, Stokes J, Gibbons L, Lindsay J, Levy I, Morrison H (1998) Monograph Series on aging-related diseases. X: Prostate cancer. Chron Dis Can 19: 1-18.
43. Giovannucci E, Rimm EB, Colditz GA, et al. (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85: 1571-1579.
44. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (1998) Vegetable and fruit consumption and prostate cancer risk: a cohort study in the Netherlands. Cancer Epidemiol Biomarkers Prev 7: 673-680.
45. Clinton SK, Emenhiser C, Schwartz SJ, et al. (1996) Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5: 823-833.
46. DiMascio P, Kaiser S, Sies H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274: 532-538.
47. Mills PK, Becson WL., Phillips RL, Fraser GE (1989) Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64: 598-604.
48. Schuman LM, Mandel JS, Radke A, Seal U, Halberg F (1982) Some selected features of the epidemiology of prostatic cancer. Minneapolis St. Paul, Minnesota case-control study, 1976-1979. In: Magnus K, ed. Trends in Cancer Incidence: causes and practical implications. Washington, DC: Hemisphere, pp. 345-354.
49. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willen WC (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87: 1767-1776.
50. Hsing AW, Comstock GW, Abbey H, Polk BF (1990) Serologie precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 82: 941-946.
51. Nomura AM, Stemmerman GN, Lee J, Craft NE (1997) Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6: 487-491.
52. Weisburger JH (1998) Evaluation of the evidence on the role of tomato products in disease prevention. Proc Soc Exp Biol Med 218: 140-143.